Boston Scientific Layoffs: Up to $300M Budgeted for Job Cuts
Boston Scientific layoffs began reaching employees this week, and the company still won't say how many jobs are going or which sites will lose them. On October 28, 2026, the day it reported third-quarter results, Boston Scientific told the Minnesota Star Tribune that "some employees impacted by the global restructuring plan have been notified this week." The plan behind the cuts was approved by the board on July 21 and carries up to $300 million in estimated termination benefits through the end of 2029. The Marlborough, Massachusetts medical device maker disclosed the notifications on the same day it cut its 2026 forecast for a third time.
Quick Answer
- Boston Scientific confirmed on October 28, 2026 that some employees affected by its global restructuring plan were notified that week, without giving a headcount or a list of sites.
- Termination benefits make up $275 million to $300 million of the plan's $700 million to $800 million in estimated charges, about 38% at the midpoint, while moving production lines between plants is the largest single cost at $300 million to $350 million.
- The July 8-K never mentions artificial intelligence, but CFO Jonathan Monson named AI on the October 28 earnings call as one of the tools for reworking the supply chain.
What did Boston Scientific disclose about the layoffs?
Boston Scientific disclosed a global restructuring program with "some headcount reductions" in a Form 8-K filed with the SEC on July 27, 2026. The 8-K filing says the board approved the 2026 Restructuring Plan on July 21, that work starts in 2026, and that it should be substantially complete by the end of 2029. It lists three activities: supply chain optimization, including transferring certain production lines among facilities; targeted functional transformation; and organizational structure evolution.
The money is specific even though the headcount is not. The company estimates total pre-tax charges of $700 million to $800 million, of which $600 million to $700 million will be paid in cash. It expects the plan to cut gross annual pre-tax expenses by about $500 million once the benefits arrive, and it says a substantial portion of those savings will be reinvested in growth.
Here is how the charges break down by type, using the company's own table:
- Transfer costs: $300 million to $350 million, defined as the cost of moving product manufacturing lines between geographically dispersed facilities.
- Termination benefits: $275 million to $300 million, which is severance and related pay for employees whose jobs are eliminated.
- Other costs: $125 million to $150 million, covering consulting fees, contract cancellations, program management, accelerated depreciation and fixed asset write-offs.
The October 28 earnings call added the human side. CEO Mike Mahoney told analysts the company is implementing a restructuring that targets both discretionary spending and headcount, and that it wants to "delayer the company a bit more" by widening spans of control, according to the Q3 2026 earnings call transcript. The Star Tribune quoted him describing the program as "a pretty meaningful restructuring." CFO Jonathan Monson said more than half of the roughly $500 million in savings should land by the end of 2027 and that the program is tracking slightly ahead of schedule.
What is still missing matters as much as what was said. Boston Scientific has not published a job count, a list of affected plants, or a split between manufacturing, commercial and corporate roles. Every number you see attached to these cuts is a cost estimate, not a headcount.
Who was actually cut, and where?
Boston Scientific has confirmed four locations so far, and none with a role count. The pieces come from separate disclosures in four countries, so it helps to see them side by side.
Ireland: The Department of Enterprise received a collective redundancy notification from Boston Scientific on July 22, 2026, one day after the board vote, RTE News reported. Such notices are required when 30 or more job losses are possible. Boston Scientific employs more than 7,000 people in Galway, Cork and Clonmel, and the company said it does not usually break out program details by business, region or function.
Costa Rica: The company confirmed to The Tico Times on July 30 that its Costa Rican operation is part of the reorganization, while declining to give numbers or affected areas. Its Costa Rica payroll spans San José, Alajuela, Cartago and Heredia, and the company has given conflicting local headcounts of about 10,000 and about 12,000.
Houston to Minnesota: The Boston Business Journal reported on July 29 that Boston Scientific is "cutting a chunk of its Houston workforce and moving jobs to a Minnesota location." No count or site was published.
Twin Cities: About 10,000 Boston Scientific employees work in the Twin Cities, roughly one-sixth of the company's workforce, according to the Star Tribune. The heart device businesses based in Maple Grove and Arden Hills are the ones that slowed this year, but the company has not said how the cuts will split across Minnesota.
So who is most exposed? And how would you know before a letter arrives?
In practice, the plan's structure tells you more about who is exposed than any statement has. Production line transfers point to plant staff on lines that move. The "delayer" comment points to middle managers. The CFO's description of back-office transformation points to corporate functions such as finance and HR.
Picture a manufacturing engineer on the Watchman line in Maple Grove. Watchman sales fell 6% last quarter, the plan funds moving lines between plants, and Minnesota holds a sixth of the workforce. That engineer hasn't received a notice, but they have every reason to update their resume this week rather than next month.
How this fits the pattern of Boston Scientific layoffs
Boston Scientific has run several job-cutting or consolidation rounds since 2020, usually after a product decision or an acquisition, and many of them routed work into Minnesota. The 2026 plan is different in scale because it is companywide rather than tied to one product.
- November 2020: After retiring the Lotus Edge aortic valve, Boston Scientific filed a notice with Minnesota's Department of Employment and Economic Development covering 106 employees at its Maple Grove site, with layoffs beginning around January 19, 2021, KSTP reported.
- February 2023: A WARN letter dated February 22 covered 120 jobs at the Houston site acquired with Preventice Solutions, with work moving to Arden Hills, Minnesota, MedTech Dive reported. A spokesperson called it a relocation rather than a staff reduction.
- October 2024: The company said it would close Silk Road Medical's Sunnyvale, California headquarters, lay off 138 people and consolidate the work in Plymouth, Minnesota.
- May 2025: Boston Scientific announced in an 8-K dated May 28, 2025 that it was discontinuing worldwide sales of its Acurate aortic valve systems. A spokesperson told the Star Tribune that jobs would be eliminated, without giving a number, and that some staff would move to priority programs.
- July 21, 2026: The board approved the 2026 Restructuring Plan, disclosed in the 8-K filed July 27.
- July 22 to July 30, 2026: Ireland received its collective redundancy notification, Houston cuts were reported, and Costa Rica was confirmed as part of the plan.
- October 28, 2026: The company confirmed that employees were notified that week.
The earlier rounds share one trait that matters for anyone affected now. In the 2023 Houston move and the 2024 Silk Road Medical closure, Boston Scientific invited affected staff to apply for internal roles and offered relocation to Minnesota. The 8-K uses similar language, saying new jobs are being created in growth areas. If you get a notice, ask directly whether internal postings are open to you before your last day.
Why the Boston Scientific filing never mentions AI
The 8-K that launched the 2026 plan doesn't contain the words "artificial intelligence" or "AI." The earnings call does. CFO Jonathan Monson told Citi analyst Joanne Wuensch that the supply chain part of the restructuring is meant to make better use of "technology, AI" across the network.
That gap is the real story. The filing that carries legal weight explains the cuts with supply chain moves and org changes. The executive commentary to investors names AI as one of several levers for delivering the savings.
The stated trigger is a sales slowdown, not automation. Watchman sales dropped 6% in the third quarter after growing nearly 30% in 2025, and electrophysiology sales fell 5% as competition in pulsed field ablation intensified. A cybersecurity incident first reported on August 26, 2026 then disrupted the global network for eight business days, during which the company could not make or ship product, according to CFO Jonathan Monson.
None of that is automation.
So treat AI here as an efficiency tool inside a cost program, not as the cause. That distinction is useful in interviews too, because "my role was cut when the company restructured after two key product lines slowed" is a cleaner story than one built around automation.
Other companies have been more direct on paper. Oracle's quarterly filing names the adoption and integration of artificial intelligence technologies as part of its own restructuring, which we unpack in our breakdown of the Oracle restructuring plan. Boston Scientific has chosen not to put AI in writing, and that choice is itself a signal about how it wants the cuts read.
What the Boston Scientific numbers show about the medtech slowdown
Boston Scientific grew revenue just 1.5% in the third quarter of 2026, to $5.138 billion according to the company's third-quarter results release. Adjusted earnings per share came in at $0.73, down from $0.75 a year earlier. Mahoney called it "a challenging year for Boston Scientific" in the release.
The forecast cuts tell the rest. MedTech Dive reported that full-year revenue growth guidance fell to about 4.25%, from a prior range of 5.5% to 6.5% and an outlook of 10.5% to 11.5% in February. Shares fell nearly 7% to $42.02 at the open, according to MedTech Dive, and the Star Tribune reported them down about 4% at midday.
The outlook for 2027 is the part employees should weigh most heavily. On the call, Mahoney said, "we believe we will be challenged to grow sales and adjusted EPS in 2027 excluding our pending acquisition of Penumbra." The $14.5 billion Penumbra deal is now expected to close in early 2027.
Boston Scientific sits in a broader 2026 pattern where companies mention AI to investors while their formal documents stay silent or vague. Our tracker of AI and tech layoffs in 2026 separates the companies that tied cuts to AI in filings from those that only said it on calls, with the evidence behind each.
Other Minnesota manufacturers have been more specific about sites. 3M filed a WARN notice covering 62 positions at its Fairmont, Minnesota plant, as detailed in our coverage of the 3M Fairmont plant closure, which makes Boston Scientific's silence on locations stand out.
As of October 29, Final Round AI found no 2026 Boston Scientific WARN notice on Minnesota's state list or on Massachusetts WARN trackers. The federal WARN Act definitions only cover plant closings and mass layoffs that cross set thresholds at a single site of employment, so cuts spread thinly across many sites can arrive without one.
What to do if you were affected by the Boston Scientific layoffs
Start your search the day you get notice, not the day your access ends. If your role is covered by a US WARN notice, the federal WARN Act requires at least 60 days of notice, and that is paid search time. Without a WARN notice, assume your runway is shorter and act on it now.
- Ask about internal roles first. The 8-K says jobs are being created in growth areas, and past consolidations offered relocation to Minnesota.
- Export your proof of work. Save performance reviews, project metrics and any awards (only what your separation agreement lets you keep) before your laptop is collected.
- Line up references. Many employers verify employment and run a background check before an offer, so confirm two former managers will vouch for you.
- Read the severance terms before signing. Check the release, any non-compete language, and how long health coverage lasts.
- Map your skills to adjacent employers. Quality, regulatory and manufacturing engineering skills transfer to other device makers, contract manufacturers and pharma.
If your background is in software, data or engineering inside a medtech company, this guide on how to land a tech job after a layoff walks through the first 30 days, from rebuilding your resume around measurable outcomes to the outreach that gets replies.
Interview skills fade fast after a few years in one role. Running a few practice interviews with an AI interviewer before your first real screen lets you hear how your answers sound and fix the weak ones while the stakes are low.
How to explain a Boston Scientific layoff in your next interview
Lead with the company context, keep it to two sentences, and move to what you want next. Most interviewers in 2026 have seen enough restructuring to accept a layoff without suspicion, as long as your story is short, factual and consistent with what your references will say.
A version that works: "Boston Scientific launched a global restructuring in 2026 to save about $500 million a year, and my role was part of that. I am looking for a team where I can keep building on the quality and manufacturing work I led on the Watchman line." Swap in your own function and product.
The follow-up question is usually some form of why did you leave your last job, and the trap is over-explaining. Name the restructuring once, don't speculate about who was chosen or why, and move to a specific accomplishment with a number attached.
Consistency is the part people miss. One reply in a community thread where candidates compare how they answer the why-did-you-leave question after a layoff warns that a reference check can expose an exit story that does not match what your former manager says.
For live interviews, real-time interview help from Final Round AI's Interview CoPilot™ listens to the question and suggests a structured answer in a private window only you can see. It is useful when a hiring manager pushes on the layoff with a follow-up you did not rehearse.
For more coverage of company restructurings and what they mean for job seekers, browse the latest layoff and hiring news.
Author's Comment
"When a company confirms cuts but withholds the number, the searches I watch shift fast from the company name to site names like Maple Grove, Galway or Cartago. People are trying to work out whether they are next before anyone tells them. My honest advice is to stop refreshing the news and act as if your notice period has already started, because the employees who prepare during the silence are the ones with interviews booked when the letters arrive."
Jaya Muvania, SEO Specialist, Final Round AI
Related Guides
- Healthcare Layoffs: 626 Roles Cut, and AI Is Not Why
- GSK Layoffs: Up to 1,217 Jobs at Risk in Belgium
- How To Explain Layoffs in Interviews Without Sounding Negative?
- Post-Layoff Job Search Guide for 2026
Get ready for your next round
A restructuring notice changes your timeline, not your value. Final Round AI helps you prepare for each role with a Goal built from the job description and your resume, practice the hard questions, and review an automatic debrief after every session. Download the app and get Interview CoPilot™ working on your next interview, because your next round is the one that counts.
Frequently Asked Questions
How many employees did Boston Scientific lay off in October 2026?
Boston Scientific has not released a number. The company told the Minnesota Star Tribune on October 28, 2026 that some employees affected by its global restructuring plan were notified that week. The only hard figure tied to people is in its July 8-K filing: $275 million to $300 million in estimated termination benefits over the life of the plan, which runs to the end of 2029.
Why is Boston Scientific laying off employees?
The cuts belong to a 2026 restructuring plan that the board approved on July 21. Management wants about $500 million a year in gross savings while two key growth drivers slow down. Watchman sales fell 6% and electrophysiology sales fell 5% in the third quarter, and an August cyberattack disrupted ordering, manufacturing and shipping.
Are the Boston Scientific layoffs because of AI?
The company has not blamed AI. Its 8-K describes supply chain optimization, production line transfers and changes to the organizational structure, and it never mentions artificial intelligence. On the October 28 earnings call, CFO Jonathan Monson listed AI as one of several tools for reworking the supply chain, which makes AI part of how the savings get delivered rather than the stated reason for them.
Which roles did Boston Scientific cut?
No role list has been published, and Final Round AI found no state WARN notice naming job titles as of October 29. The plan's design points to manufacturing staff on production lines that move between plants, back-office functions, and management layers, since CEO Mike Mahoney said the company wants to delayer the organization. Ireland, Costa Rica, Houston and the Twin Cities are the locations named so far.
Is Boston Scientific still hiring after the layoffs?
Yes, in some areas. The July 8-K says new jobs are being created in growth areas even as headcount falls elsewhere, and the company plans to reinvest a substantial portion of the savings in growth initiatives. In earlier consolidations, including the 2023 Houston move and the 2024 Silk Road Medical closure, affected staff could apply for internal roles, and some were offered relocation to Minnesota.
Table of Contents
Related articles
Flutter Layoffs: Paddy Power Owner to Cut Up to 1,400 Jobs
Flutter layoffs: the Paddy Power owner plans up to 1,400 UK and Ireland redundancies. What the 8-K says, who is affected and how to explain it in interviews.
Essendant Layoffs: 1,278 Cut as Company Says It Will Close
Essendant layoffs hit 1,278 jobs across six states as the wholesaler tells regulators it expects to cease operations. What affected workers should do next.
Mark Cuban Tells New Grads to Work for Small Businesses
Mark Cuban says new grads should skip big companies and start at small businesses. Here's his full reasoning and why it makes sense in the AI era.
Verizon Plans to Lay Off 15,000 Employees in Biggest Job Cut Ever
Verizon will cut about 15,000 jobs, or 15 percent of its workforce, as part of a major restructuring under new CEO Dan Schulman.
